Omeros Corporation
OMER
#6443
Rank
โ‚น69.10 B
Marketcap
โ‚น974.72
Share price
-1.63%
Change (1 day)
3.70%
Change (1 year)

Earnings for Omeros Corporation (OMER)

Earnings in 2025 (TTM): -โ‚น10.75 Billion

According to Omeros Corporation's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -โ‚น14.2 Billion a decrease over its 2023 earnings that were of -โ‚น12.95 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Omeros Corporation from 2009 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚น10.75 Billion-24.24%
2024 -โ‚น14.2 Billion9.63%
2023 -โ‚น12.95 Billion-9.57%
2022 -โ‚น14.32 Billion-30.65%
2021 -โ‚น20.64 Billion86.28%
2020 -โ‚น11.08 Billion99.45%
2019 -โ‚น5.56 Billion-49.91%
2018 -โ‚น11.09 Billion190.77%
2017 -โ‚น3.82 Billion-27.96%
2016 -โ‚น5.3 Billion-17.61%
2015 -โ‚น6.43 Billion1.88%
2014 -โ‚น6.31 Billion87.56%
2013 -โ‚น3.37 Billion
2011 -โ‚น2.47 Billion-8.96%
2010 -โ‚น2.71 Billion45.03%
2009 -โ‚น1.87 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Eterna Therapeutics
ERNA
-โ‚น0.86 Billion-92.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Genetic Technologies
GENE
-โ‚น0.35 Billion-96.94%๐Ÿ‡ฆ๐Ÿ‡บ Australia
Pfizer
PFE
โ‚น1.064 T-9,490.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚น2.910 T-25,768.33%๐Ÿ‡บ๐Ÿ‡ธ USA